Microbot Medical Inc - Asset Resilience Ratio
Microbot Medical Inc (MBOT) has an Asset Resilience Ratio of 89.84% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Microbot Medical Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2024)
This chart shows how Microbot Medical Inc's Asset Resilience Ratio has changed over time. See MBOT net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Microbot Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Microbot Medical Inc market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $73.45 Million | 89.84% |
| Total Liquid Assets | $73.45 Million | 89.84% |
Asset Resilience Insights
- Very High Liquidity: Microbot Medical Inc maintains exceptional liquid asset reserves at 89.84% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Microbot Medical Inc Industry Peers by Asset Resilience Ratio
Compare Microbot Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for Microbot Medical Inc (1998–2024)
The table below shows the annual Asset Resilience Ratio data for Microbot Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 39.06% | $2.36 Million | $6.03 Million | -7.97pp |
| 2023-12-31 | 47.04% | $3.92 Million | $8.33 Million | -13.36pp |
| 2022-12-31 | 60.40% | $5.76 Million | $9.54 Million | +48.47pp |
| 2021-12-31 | 11.92% | $2.00 Million | $16.77 Million | -7.10pp |
| 2020-12-31 | 19.02% | $5.00 Million | $26.28 Million | +12.23pp |
| 2019-12-31 | 6.79% | $2.52 Million | $37.13 Million | +6.55pp |
| 2017-12-31 | 0.25% | $27.00K | $11.02 Million | -14.75pp |
| 2016-12-31 | 14.99% | $505.00K | $3.37 Million | +70.01pp |
| 2015-12-31 | -55.02% | $-11.67 Million | $21.22 Million | -55.02pp |
| 2014-12-31 | 0.00% | $-397.00 | $32.43 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $41.56 Million | -- |
| 2012-12-31 | 46.07% | $13.90 Million | $30.17 Million | +33.06pp |
| 2011-12-31 | 13.02% | $3.28 Million | $25.21 Million | +12.39pp |
| 2010-12-31 | 0.62% | $190.80K | $30.60 Million | +0.24pp |
| 2009-12-31 | 0.38% | $197.00K | $51.19 Million | -9.76pp |
| 2008-12-31 | 10.14% | $4.18 Million | $41.23 Million | -45.15pp |
| 2007-12-31 | 55.29% | $26.70 Million | $48.28 Million | +49.11pp |
| 2006-12-31 | 6.18% | $4.13 Million | $66.86 Million | -48.71pp |
| 2000-12-31 | 54.90% | $16.36 Million | $29.79 Million | +26.02pp |
| 1998-12-31 | 28.88% | $9.50 Million | $32.90 Million | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination f… Read more